GERO
SCIENTIFIC ADVISORY BOARD
Robert J. Shmookler Reis, PhD
Professor and Udupa Chair in Geriatrics, Reynolds Institute on Aging
Professor, Univ. of Arkansas for Medical Sciences
Dr. Reis is a pioneer of longevity genetics and age-associated diseases. He developed methods to identify and characterize genes that govern lifespan in C. elegans. His group was the first to define genetic loci that modulate longevity, Darwinian fitness, and stress resistance. They have also discovered the role of Pirin gene on the X chromosome as a determinant of post-menopausal bone loss in women and pioneered studies of homologous recombination and its roles in the etiology and progression of myeloma, prostate and breast cancers.
Mark Philip, PhD
PhD from Nottingham Trent University, UK
Mark Philip is an expert in strategy development, product development, business development, fundraising and commercial planning for biotech companies. He has over 25 years of experience of managing businesses, both small and large, primarily in the pharmaceutical, biotechnology, medical device and diagnostics industry. With expertise in strategic planning, operations, product and business development, sales and marketing, Mark has orchestrated multiple turnarounds, built product pipelines, launched new products, sold companies and created significant stakeholder value.
Aubrey De Grey, PhD
Founder and Chief Science Officer of the SENS Research Foundation
Dr. de Grey is one of the most renown gerontologists and public figures in aging. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge. Dr. de Grey is the Editor-in-Chief of Rejuvenation Research, the world highest-impact peer-reviewed journal focused on interventions in aging. He is also a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous other journals and organizations.
Dobri Kiprov, MD
Chief of the Division of Immunotherapy at California Pacific Medical Center
Medical Director of Apheresis Care Group (ACG)
Dr. Kiprov has worked in the field of therapeutic apheresis for more than 25 years and published numerous scientific papers on the subject. He served two terms on the American Society for Apheresis (ASFA) and received the ASFA Presidential Award for his pioneering work and significant contribution.
With his immunology and apheresis background, Dr. Kiprov has been a vital part of the first trials of immunotherapy (cell therapies) and is currently involved in several projects involving cell vaccines and stem cell therapies.